India, Sept. 11 -- The Government of India issued the following news release:
In line with the Prime Minister's vision of Atmanirbhar Bharat and contributing to India's aspiration of becoming a global leader in affordable healthcare technologies, the Technology Development Board (TDB), Department of Science and Technology, Government of India, has extended support to M/s Aodh Lifesciences Pvt. Ltd., Hyderabad for development of Indigenous Antibiotic Nebulization Suspension for Pneumonia (AONEUM-04) and Antimicrobial Resistance (AMR).
The novel technology represents a paradigm shift in antibiotic delivery. Unlike conventional oral or intravenous therapies, AONEUM-04 enables direct, localized delivery of Antibioticthrough nebulization, ensu...